Nonalcoholic fatty liver disease and lipids
Current Opinion in Lipidology, 08/03/2012
Wierzbicki AS et al. – Hypoglycaemic and lipid–lowering therapies may have a role in the treatment of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis but large scale endpoint trials remain to be performed.



